Acute metabolic acidosis enhances circulating
parathyroid hormone, which contributes to the
renal response against acidosis in the rat.
M Bichara, … , P Borensztein, M Paillard
J Clin Invest.
1990;
86(2)
:430-443.
https://doi.org/10.1172/JCI114729
.
Acute PTH administration enhances final urine acidification in the rat. HCl was infused
during 3 h in rats to determine the parathyroid and renal responses to acute metabolic
acidosis. Serum immunoreactive PTH (iPTH) concentration significantly increased and
nephrogenous adenosine 3H,5H-cyclic monophosphate tended to increase during HCl
loading in intact and adrenalectomized (ADX) rats despite significant increments in plasma
ionized calcium. Strong linear relationships existed between serum iPTH concentration and
arterial bicarbonate or proton concentration (P less than 0.0001). Serum iPth concentration
and NcAMP remained stable in intact time-control rats and decreased in CaCl2-infused,
nonacidotic animals. Urinary acidification was markedly reduced in parathyroidectomized
(PTX) as compared with intact rats during both basal and acidosis states; human
PTH-(1-34) infusion in PTX rats restored in a dose-dependent manner the ability of the kidney to
acidify the urine and excrete net acid. Acidosis-induced increase in urinary net acid
excretion was observed in intact, PTX, and ADX, but not in ADX-thyroparathyroidectomized
rats. We conclude that (a) acute metabolic acidosis enhances circulating PTH activity, and
(b) PTH markedly contributes to the renal response against acute metabolic acidosis by
enhancing urinary acidification.
Research Article
Acute Metabolic
Acidosis Enhances Circulating Parathyroid
Hormone,
Which
Contributes
to
the Renal
Response against Acidosis in the Rat
Maurice Bichara, OdileMercier, Pascale Borensztein, and Michel Paillard
Laboratoire de PhysiologieetEndocrinologieRe'nale, UniversitePierreetMarie Curie,H6pitalBroussais;
and the Institut National de laSanteetde la RechercheMedicaleCJF88-07, Paris, France
Abstract
Acute PTH
administration
enhances final urine acidification in the rat.HCl
wasinfused
during3
h in rats to determine theparathyroid
and renal responses to acute metabolic acidosis.Serum immunoreactive
PTH(iPTH) concentration
signifi-cantly increased andnephrogenous
adenosine3',5'-cyclic
monophosphate
tended to increase duringHCO
loading in intact andadrenalectomized
(ADX) rats despitesignificant
incre-mentsin
plasmaionized calcium.
Strong linearrelationships
existedbetween serum iPTHconcentration
and arterial bicar-bonate or protonconcentration
(P <0.0001).
SerumiPTH
concentration
and NcAMP remained stable in intact time-con-trol ratsand decreased inCaCl2-infused,
nonacidotic animals.
Urinary acidification
wasmarkedly reduced inparathyroidec-tomized
(PTX)
ascompared with intact rats during both basal andacidosis
states; humanPTH-(1-34) infusion
in PTXrats restored in adose-dependent
manner the ability of the kidney toacidify
the urine and excrete netacid.
Acidosis-induced increase in urinary net acid excretion was observed in in-tact,PTX,
and ADX, but not in ADX-thyroparathyroidecto-mized rats.We conclude that
(a)
acutemetabolic
acidosis enhancescirculating
PTHactivity,
and(b)
PTHmarkedlycontributes
to therenal responseagainst
acutemetabolic acidosis
by
enhanc-ingurinaryacidification.
(J.Clin.
Invest. 1990.86:430-443.)
Key words: acidosis *PTH
-urinary acid
excretionIntroduction
Acute PTH
administration
wasgenerally
considered to in-creaseurinary
bicarbonate excretionsecondary
toinhibitionof bicarbonate
reabsorption
intheproximal
tubule.However,
we have shown in rats(1)
that thereported
acute bicarbona-turiceffect of
PTHis secondary
to anearly
transient increasein the GFR
and thusbicarbonate-filtered
load duetothevaso-dilatory
properties
of
PTH. When this initialhemodynamic
Partsof thiswork werepresentedat the 21st AnnualMeeting of the
AmericanSociety ofNephrology,San Antonio,TX, December1988, andwerepublishedin abstract form (1989, KidneyInt. 35:389; and
1990, Kidney Int. 37:464).
Address correspondenceand reprint requests to Dr. M. Bichara
and Dr. M.Paillard, LaboratoiredePhysiologie, Hopital Broussais,96 rueDidot, 75675 Paris cedex 14,France.
Receivedfor publication23February 1989 and in revisedform 6 March 1990.
PTH
effect
has vanished, i.e., after- 1 h in the rat under theconditions of
our study (1), thePTH-induced
inhibition ofbicarbonate
andchloride in
theproximal
convoluted tubule iscounterbalanced
by anopposite effect
insuperficial
Henle's loop so that the early distal delivery as-well as the excretion infinal
urineof
these anions are unchanged during PTH infusion (1). Infact,
we (1) and Bank and Aynedjian (2) have found that PTHadministration dramatically enhances
urinaryacidifica-tion.
PTHinfusion
inthyroparathyroidectomized
(TPTX)'
rats wasassociated
in the steady statewith
a decrease in uri-nary pH and an increase in uriuri-narytitratable acid,2
ammo-nium,
andthus
netacid excretion
(1, 2). We haveestablished
that protonsecretion in collecting
ducts isstimulated
during PTHinfusion indirectly via
thePTH-induced increase in
uri-naryphosphate concentration
(1, 3). Inagreement with
the acutePTH-induced
stimulation of urine acidification just
de-scribed, chronic
PTHadministration induces sustained
meta-bolic
alkalosis,
atleast in partof
renalorigin,
in human (4),dog (5-7),
and rat(8,
andunpublished observations from
our laboratory). Also, resultsof
a recent studyconducted.
in our laboratory havedemonstrated
thatchronic neutral phosphate
administration
in the rat, such assodium
andpotassium
salts,induces
renalmetabolic
alkalosis secondary
tosustained
in-creased protonsecretion in collecting ducts during
up to 7 d (9).Finally,
we have shown(10)
thathypercalcemia
per seincreases
theproximal
and thus renalreabsorption of
bicar-bonaterelative
tochloride, which,
if
of
sufficient
magnitude
and/or
duration,
wouldinduce
hyperbicarbonatemia
andhy-pochloremia;
this calcium effect
onthe
proximal
tubule mayexplain
thechronic metabolic
alkalosis,
atleastin
partof
renalorigin, associated with
hypercalcemia
secondary
tohyperpara-thyroidism
or1,25-dihydroxycholecalciferol
administration
(6, 8),
or observed inpatients
with various
neoplasms (1
1).
Thus
PTH, urinary
phosphate,
and
plasma
calcium aremajor determinants of
urinary acidification,
a rise in eachof
these threefactors
being capable
of
enhancing
netacidexcre-tion.
Theaim of this
study, therefore,
was to determine whether acuteacid
loading
acts onthe
circulating
PTHcon-centration
and whetherPTH contributes toenhancementofnet
acid
excretion
during
an acutemetabolic
acidosis. Theresults
demonstratefor
thefirst time
in theratthat theserum1.Abbreviations usedin this
paper:
ADX, adrenalectomized; iPTH,immunoreactivePTH; NcAMP, nephrogenousadenosine
3',5'-cyclic
monophosphate; PTX, parathyroidectomized; TPTX,
thyroparathy-roidectomized.
2. Titratable acidrepresents theamountof acid that has titratedthe
urine buffers fromtheplasma pHtourinepH.Theterm"ammonia"
willreferto the sumof free-base ammonia (NH3)andammonium ion
(NH').
Theterm"netacid excretion" will refertothesumofammo-niumplus
titratable
acid minusbicarbonate intheurine.430 M.Bichara, 0.Mercier,P.Borensztein,and M. Paillard
J.Clin.Invest.
© The AmericanSocietyfor ClinicalInvestigation,Inc. 0021-9738/90/08/430/14 $2.00
immunoreactive PTH (iPTH) concentration rises during
HCI
loading, and that PTH contributes to the renal response against acute metabolic acidosis by enhancing urinary ammo-nium, phosphate, and titratable acid, and thus net acid excre-tion.Methods
Animals
59 male Sprague-Dawley rats weighing 305±4 g (mean±SE) were stud-ied. They had been fed a standard commercial chow (A 04; UAR, Villemoisson-sur-Orge, France) containing 5.9 g/kg phosphorus, 6.0 g/kg calcium, and 2,020 IU/kg vitamin D3 for at least 7 d before the study. Foodwaswithheld14-16 hbeforetheexperiment, but all ani-mals hadfree access to water before anesthetization with Inactin
(5-ethyl-5-[I-methyl-propyl]-2-thiobarbituric acid), 100 mg/kg body wt. Each ratwasstudied initially during a 60-min control period while receiving for4h aninfusion of a 125-mM NaCl solution at 0.6
Ml/min
per g body wtand thenduring a 3-h experimental procedure. The experimental procedure waseitheran infusion of HCO (50mM
HCl
replacing 50mMNaCl in the infused solution, 30 nmol H+/min per g body wt),aninfusion of calcium chloride (7 nmol/min per g body wt),
oratime control. Thus,aslightly hypotonic fluid volume expansion wasinduced early during the preparatory surgery and maintained throughout the experiment in eachrat tominimize possible variations in the extracellular fluid volume and circulating antidiuretic hormone activity, sincewehave shown that thelatterareimportant determi-nantsoftubule fluid and urine acidification (12, 13). Since the purpose ofthis studywas todetermine the place ofPTHduringacutemetabolic acidosis, intact,parathyroidectomized(PTX), TPTX, and adrenalec-tomized(ADX)rats werestudied.ADX rats werealsostudied because endogenous aldosterone and glucocorticosteroidsecretion may be stimulated duringacidloading (14-18)and because corticosteroid hormonesareknowntoaffectvarious renal functions, including uri-nary acidification and renal handling of ammonium, phosphate, and
thustitratable acid.Varying circulatingcorticosteroid activitiesduring
acidloadingcould therefore cloud effects that may be duetoPTH,as
will be shown below. In addition, various groups of animals were
necessarytostudy theparathyroidresponsetoacidloadingon the one
hand and the renal responseonthe otherhand,becauseavolumeof blood sufficient for allmeasurementscouldnotbesampledinthesame
animal.
Serum
iPTH
and
nephrogenous
adenosine
3',5'-cyclic
monophosphate
measurements
Group I:intactHCI-loadedrats.This groupwascomposedof sixrats
thatwerestudied twice: firstduringa60-min controlperiodafter 3hof
equilibration after surgery, and second during 3 h of HCOloading.
Serum iPTH concentration andnephrogenous adenosine
3',5'-cyclic
monophosphate (NcAMP; excreted minus filteredcAMP)were deter-minedintheserats.
Group II:ADXHCl-loadedrats.This groupwascomposedof six
ratsthatwerestudiedastheratsof groupI,except thattheywereADX
3-4 hbeforethefirst controlperiod. Adequacyofadrenalectomywas
insuredbyanacceptance of the animals for thestudy onlyif the GFR
was atleast 20%belowthe normalvalue, which indicatedalow
circu-latinglevel ofglucocorticosteroidhormones.
Group III:
CaCb-infused,
nonacidoticrats. This groupwascom-posed ofthreeintactrats that werestudiedduringafirstcontrolperiod,
andthenduring3hofCaC12 infusionat7nmol/minper gbodywt.
Group IV: time-control rats. This group wascomposedofthree
intact andthree ADX ratsinwhichthe 125mMNaClsolution infu-sionwasmaintained for 3haftertheinitial controlperiodtoassessthe spontaneous evolution with time ofserum iPTH concentration, NcAMP,andurinaryphosphateexcretion.
Renal response
to
acid
loading
In all the
following
groupsthat weredesigned
to study the various components ofurinary
netacid excretion inresponsetoacutemeta-bolic
acidosis,
theanimalswerestudiedexactly
asthoseofgroups I andII,
i.e.,
during3hofHCl
loadingafterafirst 60-mincontrolperiod.STUDIESIN ADRENAL-INTACT ANIMALS
Group
V,six intactrats.Group
VI:PTXrats. Sixratsmade up this group: fourwerePTXandtwoinwhich the
parathyroid
glands
couldnotbeeasily
localizedwereTPTXatleast 3-4hbefore the first control
period.
Since therewas noobvious difference in the various measured parameters between
PTXandTPTXIdts,the resultswere
pooled
and thegroupwillhereaf-terbereferredto asthePTX group.
Group
VII:PTXratsinfused
with humanPTH-(1-34)
[hPTH-(J-34)].
Eight
rats werePTXearly during
the preparatorysurgeryandimmediately
infused withhPTH-(1-34)
atconstantrates,i.e.,
either 5-6pg/minper gbody
wt(three
rats,groupVIa)
or7-9pg/minper gbody
wt(five
rats,groupVIIb)
thatproduced,
respectively,
moderately
low and
high biological
PTHactivity
asjudged by
the valuesof ionized calcium andinorganic phosphorus plasma
concentration andurinary
fractional excretion of
inorganic phosphorus (see Results). Synthetic
hPTH-(1-34)
waschosenbecauseratPTH-( 1-84)
isnotcommercially
availableto our
knowledge.
STUDIESIN ADX ANIMALSAs
already mentioned,
ADXratswerestudiedtoassessthe renalre-sponsetoacid
loading
intheabsence ofvarying
corticosteroidcircu-lating
activitiesthatcould cloud effects thatareduetoPTH.Group
VIII: Six intactrats.Group IX:
SixADXrats.Group
X:Six ADX-TPTXrats.Surgical
and
experimental procedures
Afteranesthetizationtheratswere
placed
onaservo-regulated
heatedtable that maintained their rectaltemperatureat
370C.
Alltissue inci-sionsweremade withan electricbistoury, coagulation
wascarefully
produced
withacautery, andallexposed
surfaceswerecovered withwater-equilibrated
paraffin
oil. A PE-50 catheter(Biotrol, Paris,
France)
wasinserted into the left femoralarteryforcontinuousmoni-toring
of blood pressureand for bloodsampling;
all bloodsamples
were
quantitatively replaced by
whole blood obtainedonthemorning
of
study
from anotherratthatwasintactorTPTXtheday
before forPTX and TPTXrats. A solution
containing
125 mMNaCl,
3 mMCaCl2,
and1.5 mMMgSO4
wasinfusedthrough
PE-50 catheters intoafemoral veinat0.6
dl/min
per gbody
wtand into both externaljugular
veins at 0.02
Ml/min
per gbody
wt. Inthe PTXrats ofgroupVII,
hPTH(
1-34)
wasaddedtoonejugular
infusiontoachievehPTH(1-34)
infusionratesof 5-6or7-9pg/min
per gbody
wt.Atracheostomy
was
performed
and the ratwasattachedtoarodentrespirator
(Bio-science,
Sheemess,Kent,
UK)
and ventilated for the duration of thestudy.
The leftureter andthe bladderwere cannulated withPE-50
tubing through
anabdominalapproach.
Attheendof thesurgery,anamountof 1.5% of
plasma,
obtained from anotherratthatwasintactorTPTXthe
day
before forPTXandTPTXrats,wasadministered andfollowed
by
amaintenance infusion ofplasma
at0.05td/min
per gbody
wtthrough
ajugular
vein(plasma repletion)
aspreviously
de-scribed
(13). Through
theotherjugular
vein,
apriming
doseof12.5,gCi
of[methoxy-3H]inulin
(New
England
Nuclear, Boston,MA)
was
given
and followedby
asustaining
infusion of 0.04tiCi/h
per gbody
wt.Aftera 3-h
equilibration period,
afirst60-mincontrolperiod
wasperformed. Thereafter,
the solution infusedthrough
thefemoral veinwas
replaced
withasolutioncontaining
50mMHCl,
75 mMNaCl,
3mM
CaCI2,
and 1.5 mMMgSO4
thatwasinfusedatthesamerateof 0.6ul/min
per gbody
wtinHCl-loadedrats.IntheratsofgroupIII,
CaCl2
wasaddedtothe 125mMNaClsolutiontoachievea7nmol/
IVthe 125mMNaCI solution infusion was maintained. These experi-mental procedures lasted 3 h. Each hour two or three timed urine collections were made under water-equilibrated paraffin oil and blood samples were obtained.Anadditional urine sample was collected dur-ing the last 10 min of each period for determination of urinary cAMP in some rats.
After the completion ofthe experiment, the left kidney was excised, blotted, and weighed.
Analytical procedures
Arterial and urinary pH and Pco2 were measured by a blood gas analyzer (model BMS3 MK2; Radiometer, Copenhagen, Denmark). Urine total CO2 (dissolved CO2 and HCO ) was determined by a carbon dioxide analyzer (model 965; Corning Glass Works, Corning, NY); the urinary bicarbonate concentration was calculated as the dif-ference between the measured total CO2 and dissolvedCO2(0.031
X Pco2) concentrations. Ionized calcium concentration was deter-mined in whole blood usingacalcium ion-selective electrode (ICA 1; Radiometer). The
[methoxy-3H]inulin
radioactivity in plasma and urinewasmeasured by scintillation counting (Betamatic; Kontron, Trappes, France). Titratable acid and ammonium urinary excretion rates were determined by automated titration methods. Net acid ex-cretion ratewascalculated as the sum of that of urinary ammonium andtitratable acid minus bicarbonate. Serum iPTH concentration was measured withanintactNH2-terminal-specific PTH radioimmunoas-say(Nichols Institute Diagnostics, San JuanCapistrano, CA). The intactNH2-terminal-specificPTHradioimmunoassay kit contains chicken anti-PTH serum directed against the 1-34 region of PTH, hPTH-(1-34) standards, goat anti-chicken gamma globulin precipitat-ing antibody, and1251I-bovine
PTH-(1-84)as tracer.The useof this kit forrat PTHmeasurementhasalready been validated by others (19). All measurements were made in duplicate on 300 zI rat serum stored at -20'Cobtained from 600;d
ofbloodcollectedinto ice-chilled tubes. Theconcentration of cAMP in plasma and urinewasmeasuredbyacAMP1251 assay system kit(Amersham, LesUlis,France) that is based
onthecompetitionbetween unlabeled cAMP and
1251-labeled
cAMP foralimited number ofbindingsitesonacAMP-specific antibody. Separationof theantibody-boundfraction waseffected by magnetic separation usinga second antibodythat is bound to magnetizablepolymerparticles (Amerlex-M-second antibodyreagent). Each mea-surement wasmade induplicateon40Mlof urineorplasmastoredat
-20°C; plasma sampleswereobtained after immediatecentrifugation
of 200
Al
ofbloodcollected into ice-chilled tubes that containedafinal concentration of 10 vol% of 7.5mM EDTA.Plasma andurine magne-sium concentrations were measured by colorimetric determination(Mg-kit; Biomerieux, Paris, France). Urinary osmolality was deter-minedbyan osmometer (Fiske Osmometer, Uxbridge, MA).Other
analytical proceduresfor determination of
sodium,
potassium, chlo-ride, totalcalciub, inorganic phosphorus,andprotein
havepreviouslybeen described in detail(10, 13).
Calculations
Wholekidney GFRwasestimated from wholekidney
[methoxy-3H]-inulin clearance.Urinaryfractional excretion ofasolutexwas calcu-latedas(U/UF)x/(U/P)inulinin which U,UF,andP areurine,
ultra-filtrate,andplasmaconcentrations,respectively.Theultrafiltrate
con-centrations ofcalcium, inorganic phosphorus,andmagnesium were
takenas0.60, 0.93, and 0.80 times plasmawaterconcentrations(20), respectively.
Onlytheresultsobtained from the leftkidney,the ureterof which
was cannulated, are presented. All absolute rateswere factored by
kidneyweightto compensate for differences caused by animal size.
Kidney weights ranged from 1.00to 1.69 g with a mean value of 1.27±0.02 g.
Resultsareexpressedasmeans±SE.Statistical
significance
of dif-ferences within and between groupswasassessedby
one- ortwo-wayanalysisof varianceas
appropriate
and thettestonlywhentheFtestwassuitable.
Results
Effects
ofacid-loading
on iPTH
and
NcAMP
(groups I-IV)
The
results obtained
in groupsI-IV
aresummarized in
TableIand in
Figs.
1-3. As shown inFig. 1,
the HClinfusion
induceda
metabolic acidosis that
wassignificantly
moreseverein ADX than in intact rats.After
3 h of acidloading,
thearterial
pH
decreased
to7.27±0.02
pH
units in intact rats, and to7.19±0.02 pH units
(P
<0.001)
in ADX rats; alsointhesametime,
the
plasma
bicarbonate
concentration decreased to 14.2± 1.1 mMin
intact
rats,and
to 11.2±1.4 mM(P
<0.05)
in
ADXrats.Arterial
pH
and
plasma
bicarbonate concentration
remained stable in
CaCl2-infused
ratsof
group III(Fig. 1).
One
of the
striking
findings
of this
study
wasthat
acutemetabolic acidosis
wasassociated with
anincrease
in theserum iPTH
concentration
(Fig. 2) despite
anincrease
inthearterial ionized
calcium-
concentration(Fig. 1)
in bothintact
and
ADXanimals.
During
acid
loading,
the
serumiPTHcon-centration
progressively
increased from 21.8±3.7
to30.6±3.5
pg/ml (P
<0.005)
atthethird hour in
intact
rats,and
from
21.2±2.0
to39.1±4.4
pg/ml (P
<0.001)
in
ADX rats.Note thatthe final value
during
acid
loading
for
serumiPTH
con-centration
washigher
in
ADXthan in intact
rats(P
<0.05),
possibly
because of
a more severemetabolic
acidosis in
theformer
rats.Indeed,
when
serumiPTH
concentration
wasplotted
as afunction of
plasma
bicarbonate
orarterial
H'
concentration,
there
was nosignificant
difference
in thesignif-icant
relationships
thatwereobtained in intact and
ADX rats; the dataobtained in both
groupsof
animals
weretherefore
pooled.
Asshownin
Fig. 3,
stronglinear
relationships
existed
between
serumiPTH and
plasma
bicarbonate concentration
(r
=-0.63,
P<0.0001)
orarterial
H'
concentration
(r
=0.52,
P <0.0001);
notethat thecorrelation
coefficient
washigher
with
bicarbonate than with
H'
concentration
(which
wasalso
thecasewhen data
in intact and
ADXratsweretaken
separately).
Inthe same
time,
the arterial ionized calcium concentration
increased from 1.32±0.01
to1.35±0.01
mM(P
<0.005)
in
intact
rats, andfrom 1.325±0.006
to1.38±0.02
(P
<0.01)
in
ADXrats. InCaCl2-infused,
nonacidotic
rats,the
arterial
ion-ized
calcium concentration
similarly
increased
from
1.32±0.02
to1.37±0.07
mM(P
<0.05)
atthethird
hourof
infusion, which,
asexpected,
induced
asignificant
decrease in
the
serumiPTH
concentration from 22.7±0.4
to 14.5±1.5pg/ml (P
<0.005).
Inaddition,
the
plasma
magnesium
con-centration remained stable in these animals
(Fig. 1).
We
determined
NcAMPasanindex ofthe
biological
activ-ity
of
PTHonthekidney (21,
22).
Asshown inFig. 2,
NcAMP
tended toincrease, although
notsignificantly,
inintact
and ADXHCl-loaded
ratsin
which
theserumiPTHconcentration
increased; conversely,
NcAMPtended
todecrease inCaCl2-infused, nonacidotic
ratsin which the
serumiPTH
concentra-tion decreased.
Thus,
NcAMPwassignificantly higher
inaci-dotic
ratswith
high
iPTH
circulating
activities than in
CaCl2-infused
ratswith
lowiPTH
circulating
activities
(P
<0.025).
Finally,
asshown in Table
I,
these
various parameters
were stable in intacttime-control
rats.InADXtime-control rats,
anexpected
moderate metabolic acidosis extended
withtime,
which
wasindeed associated with
serumiPTH
concentrations
that tendedtobehigher
thanthose in
time-control intact
rats. Note thaturinary
phosphate
absolute
andfractional excretion
progressively decreased with time in time-controlintact
rats.TableL Time-control Rats
Controlperiod(h) Time-control (h)
0 1 1 2 3
Pi,mM
Intact 2.4±0.2 2.3±0.2 2.2±0.3 2.1±0.3 2.1±0.3
ADX 2.6±0.1 2.6±0.1* 2.6±0.1* 2.6±0.1* 2.5±0.1 *
Magnesium,mM
Intact 0.73±0.09 0.72±0.10 0.73±0.15 0.64±0.15 0.68±0.10 ADX 0.63±0.05 0.67±0.03 0.70±0.04 0.68±0.02 0.68±0.02 Ionizedcalcium, mM
Intact 1.30±0.02 1.29±0.01 1.28±0.02 1.27±0.01 1.27±0.01
ADX 1.30±0.03 '1.28±0.02 1.29±0.01 1.26±0.03 1.29±0.02 ArterialpH
Intact 7.38±0.01 7.44±0.02 7.42±0.02 7.44±0.01 7.41±0.02
ADX 7.39±0.01 7.38±0.01* 7.37±0.02* 7.37±0.01* 7.36±0.02*t Bicarbonate,mM
Intact 24.3±2.0 23.7±1.2 22.9±1.2 23.0±0.6 22.8±1.0 ADX 19.7±2.0* 19.2±1.9* 18.8±0.9* 16.5±2.0*$ 15.6±2.2*t iPTH,
pg/ml
Intact 26.8±2.5 23.1±3.4 25.7±3.2 24.3±3.9 26.7±2.3 ADX 29.3±7.3 27.0±3.5 28.3±6.0 28.5±4.5 33.5±2.0 GFR,
mil/min
Intact 1.16±0.13 1.06±0.15 1.06±0.15 1.04±0.10
ADX 0.89±0.12* 0.77±0.09* 0.61±0.06*t 0.57±0.12*t
Urine pH
Intact 6.43±0.02 6.55±0.10 6.62±0.08 6.60±0.10
ADX 5.49±0.08* 5.54±0.20* 5.60±0.30* 5.46±0.20* (UV)Pi, nmol/min
Intact 496±39 314±69t 251±16t 187±12t
ADX 122±46* 123±50* 135±60 159±74
(FE)Pi
Intact 0.20±0.02 0.12±0.02$ 0.11±0.01t 0.09±0.01t
ADX 0.06±0.03* 0.07±0.04 0.09±0.04 0.10±0.05 NcAMP,pmol/min
Intact 48±4 44±9 50±12 56±10
ADX 51±16 60±12 45±15 52±16
Values are means± SE inthreeintact and threeADXtime-controlrats.Pi,inorganicphosphorus; (UV),urinary excretionrate;(FE),urinary
fractional excretion. *P<0.05orlessvs. sameperiodinintactrats. * P<0.05orlessvs.controlperiodinthe same group.
Thus
it is clear that
acutemetabolic acidosis
wasassociated
with
biologically active increments
in serum iPTHconcentra-tion
independently
of
thecurrently
knownmain
acutedeter-minants
(calcium
andmagnesium) of endogenous
PTHsecre-tion.
Renal response to acid loading
The renal
response toHCO loading
wasstudied in various
groupsof
rats,which allowed
recognizing effects that
weredue
toPTH.
Studies
inadrenal-intact
rats(groups
V-VII).
Thearterial
blood
composition
in
these ratsis summarized in
TableII.
Asexpected, plasma
ionized calcium and
magnesium
concentra-tion
was lower and thatof
inorganic
phosphorus higher in
PTX ratsthan in
animals that
wereintactorPTXinfused with
hPTH-1-34)
during both control
andacidosis
periods.
Itis
important
tonotethat
during
the control
period
the values
of
plasma ionized calcium concentration (Table II)
andurinary
phosphate
fractional
excretion
(Fig. 4) produced by
infusion
in PTXratsof
hPTH-( 1-34)
at5-6(group
VIa)
and
7-9pg/min
per gbody
wt(group
VIIb)
weremoderately
lower andhigher,
respectively,
than the valuesin
intact
rats; thus thesetwohPTH-(
1-34)
infusion
ratesproduced
low-normal and
moder-ately
high
biological
PTHcirculating
activities.
SincehPTH4
1-34)
and
ratPTH-
1-84)
do
nothave
thesamemolar potencyagainst
theantiserum
used inthe
presentstudy
(19),
itwas
impossible
todirectly
comparetheir
circulating
concen-trations.
During
HCI
loading,
PTXratsdeveloped
ametabolic
aci-dosis that
wassignificantly
more severethan that
of intactorhPTH(
1-34)-infused
PTX rats;the
arterial
pH
waslower
after
2-3 hof
HCOinfusion
in PTX thanin
otherrats(Table II),
andthe decrease in
theplasma
bicarbonate concentration
washigher
in
PTX rats(-9.2±0.4
mmol/liter)
than inintact
(-8.3±0.5
mmol/liter,
P<0.05)
orPTX ratsinfused withaC Time, h C Time, h
1 2 3 1 2 3
7.41231.4102
z7:3F-F
+ 1I35+
Q. 7.2 + 1.310
7.1 - |() 1.251
251.
~~~~0.751-20-o E 0.70
-015 +c,
0.65-10 ~~~~~~~~0.60
Figure 1.ArterialpH andconcentrations of bicarbonate, ionized
cal-cium, andmagnesium duringcontrolperiod (C), 3-h HCl infusion inintact(n=6) (-)or ADX (n=6)rats(o),and 3-h
CaCI2
infusion inintactrats(n=3) (+).Magnesiumwas not measuredin CaC12-in-fusedrats.Pointsaremeans+SE.§,
P<0.05orlesscomparedwith controlperiod.(-6.8±0.3 mmol/liter,
P<0.001)
ofhPTH-(1-34).
This was due, at least in part, to the defect inurinary
acidification and netacid excretion observed
in PTX rats, which will be shown below. Two ratsof the
latter group,onePTXandoneTPTX,
died
during
the third hour ofHCO
infusion of apparent suddencirculatory
failure, probably
dueto severeacidosis.During
the controlperiod,
theGFR
wasmoderately
higher
in
PTX than in intact rats(P
<0.05,
TableIII), probably
becauseof
hypocalcemia
and absence of
circulating
PTH(1,
10);indeed, GFR values
were lowered toward controlsby
hPTH-(1-34) infusion
in PTX rats,apparently
in adose-de-pendent
manner. Note thatthe
GFRdecreased
during
acidloading
in all rats, and thatduring
thesecond
andthird
hoursof acidosis
there remained nodifference in GFR between the various groups (Table III). Also, thefiltered
loadof
bicarbon-atetended to behigher
in
PTX than inotherratsduring
the controlperiod,
butsignificantly
only
whencompared
with PTXinfused with
ahigh dose of hPTH-(1-34) (P
<0.01,
C
Time,
h
1i
2 340
35
30-
E25-0) ~~~~~~~t
0.
20-~15
- I0.L
Figure
2.SerumiPTH
concentra-10 tion and NcAMP during controlC 60- period (C), 3-h
HCO
infusion in- , T /T intact
(n
=6)
(.)
orADX(n
=6)
s
50{),1
~~~rats
(o),
and3-hCaCl2
infusion in8
40- r. f >-intactrats(n=
3) (+).
PointsareQ. 1
/means+SE.
§,
P<0.01
orlessE-
30- t comparedwith control period.<20
1,T
t,P< 0.025 or less, values duringo I CaCl2infusion compared with Z 10 I thoseduring
HCO
infusion.55
E
-)45
r 35
E 25
a)15
5 '6
r=0.63
. P<0.0001
*
*
..
*B
.~~~ **~ U
Dua
8 10 12 14 16 18 20 22 24 26 28
Plasma
HCO3-,
mM55 U
N.45 .
E~
~
I
35 .
*-25 -m * .
E * r0.52
: 15 .% * P<0.0001
a)
5
35 40 45 50 55 60 65 70 75
Plasma H+, nM
Figure3. Relationshipsbetween serumiPTH concentrationand
arte-rial
HCO3
orH+concentration in six intact and six adrenalecto-mizedratsduring3-h HCI infusion. Eachpointrepresents asinglemeasurementinoneanimal.
Table
III);
anydifference in
thebicarbonate-filtered
load be-tween thevarious
groupsrapidly disappeared during
acidloading.
As
compared with intact
rats, amarked
defect
inurinary
acidification
andurinary excretion
ratesof
phosphate,
titrat-able
acid, ammonium,
and netacid
wasobserved
in PTXanimals
during
both control and acidosisperiods (Table III,
Figs.
4and 5).The
urinary bicarbonate excretion
rate was notsignificantly different
in PTX andintact
ratsduring
the con-trolperiod
andfirst hour
of
HCOinfusion,
andthen fell
tovery low valuesin both
groupsduring
thelast two hoursof acidosis
(Table
III); nevertheless,
theurine
pH(Table III) remained
significantly higher
in PTXthan
inintact
rats(P
<0.01)
throughout the
experiments despite
more severeacidosis
andless
urinary buffer
content (seebelow) in the former
animals;
this
obviously
wassecondary
to adefect in
collecting
duct protonsecretion in
PTX rats.There
wasalmost
nophosphate
in theurine
of
PTX rats(Fig. 4),
and theurinary excretion
rateof titratable
acid
waslow
throughout the
experiments in
theseanimals
(Fig.
5).
Asshownin
Fig.
5,
theurinary
ammonium
excretion
rate wasalso lowerin
PTXthan inintact
ratsduring
the controlperiod
(P
<0.02);
during
acidosis,
this difference in
ammonium excretion
persisted
but tendedtodiminish.
As aresult
of these various defects, the urinary
netacid excretion
rate waslower
during control period in
PTXthan in
intact
rats(P
<0.02,
Fig. 5),
andsignificantly
remained
soduring
aci-dosis.
The
infusion
of hPTH-(1-34)
in PTX rats corrected thedefects
just
described in
adose-dependent
mannerduring
bothcontrol
andacidosis
periods.
This
was truefor the urine pH
andurinary
bicarbonate excretion
rate(Table
III),
aswell asfor
theurinary
excretion
ratesof phosphate
(Fig.
4), titratable
acid,
ammonium,
and
netacid
(Fig.
5). Moreover, from
Figs.
4and
5, it is
apparentthat
thevalues observed
inintact
ratsfor
434 M.Bichara, 0.Mercier,P.Borensztein, andM.Paillard
I
I
TableIL ArterialBlood CompositioninAdrenal-intact HCl-loaded Rats (Groups V-
VII)
Control period (h) HCI-loading(h)
0 1 1 2 3
Hematocrit,vol%
Intact 44.5±0.8 44.4±0.9 46.6±0.9 45.9±1.2 46.0±1.3
PTX 44.9±1.0 45.4±1.0 47.2±1.4 47.0±1.6 46.6±2.0
PTX +low
hPTH-(1-34)
44.8±0.5 45.7±0.6 46.9±0.5 47.1±1.1 46.8±1.9 PTX+highhPTH.(1-34) 43.7±1.2 44.1±0.8 46.1±0.9 45.8±1.0 46.8±0.9 Protein, g/dlIntact 4.4±0.2 4.5±0.2 4.5±0.2 4.4±0.3 4.3±0.2
PTX 4.5±0.1 4.4±0.1 4.4±0.1 4.3±0.2 4.1±0.2 PTX+low
hPTH.(1-34)
4.1±0.3 4.3±0.3 4.2±0.2 4.2±0.2 4.1±0.3PTX +high hPTH-(1-34) 4.3±0.2 4.2±0.1 4.3±0.1 4.2±0.1 4.3±0.1 Sodium, mM
Intact 147±1 147±1 144±1 141±2* 138±2* PTX 146±1 145±2 142±2 140±2* 138±3*
PTX+low
hPTH.(1-34)
147±3 148±3 145±2 142±3* 138±2*PTX+high
hPTH.(1-34)
146±1 145±1 143±1 140±1* 138±1*Potassium,mM
Intact 3.9±0.1 3.9±0.1 4.1±0.1 4.2±0.1 4.1±0.1 PTX 3.5±0.1I
3.4±0.1*
3.5±0.1I3.7±0.1*
3.8±0.3PTX+lowhPTH-(1-34) 3.8±0.1§ 3.7±0.1§ 3.8±0.1§ 4.0±0.1 4.3±0.2
PTX +highhPTH-(1-34) 3.9±0.1§ 3.8±0.1§ 3.8±0.1§
4.0±0.1
4.1±0.1Chloride, meqlliter
Intact 112±1 112±2 113±2 113±2 115±2*
PTX 110±1 109±2 110±2 112±2* 112±2*
PTX+lowhPTH-(1-34) 115±3 116±3 116±2 115±2 117±3
PTX+highhPTH-(1-34) 112±1 113±1 114±1 114±1 114±1
Pi, mM
Intact 2.20±0.05 2.11±0.06 2.12±0.06 1.95±0.16 2.11±0.08 PTX
2.55±0.11*
2.59±0.10*
2.73±0.11t 2.82±0.12*$ 3.10±0.05*$PTX +lowhPTH-(1-34) 2.20±0.07§ 2.23±0.07§ 2.24±0.04§ 2.25±0.05§ 2.26±0.08§
PTX+high
hPTH.(1-34)
1.95±0.07*1
1.86±0.06*11
1.87±0.06*11
1.81±0.08§"
1.85±0.07*11 Magnesium,mMIntact 0.65±0.01 0.63±0.01 0.65±0.02 0.66±0.03 0.74±0.07
PTX
0.54±0.02*
0.52±0.03*
0.53±0.04*
0.58±0.03 0.62±0.05*PTX+lowhPTH-(1-34) 0.62±0.04§ 0.59±0.04§ 0.58±0.02 0.57±0.04 0.63±0.04 PTX+high
hPTH.{1-34)
0.63±0.01§ 0.61±0.02§ 0.60±0.03§ 0.59±0.04 0.63±0.06 Totalcalcium,mMIntact 2.15±0.03 2.15±0.04 2.17±0.04 2.17±0.05 2.15±0.05
PTX 1.80±0.03*
1.75±0.07*
1.76±0.04*
1.77±0.05*
1.75+0.05*PTX+lowhPTH-(1-34) 2.06±0.05§ 2.10±0.03§ 2.10±0.02§ 2.09±0.05§ 2.06±0.06§
PTX+high hPTH-(1-34) 2.18±0.05§ 2.24±0.05§11
2.28±0.03§11
2.20±0.055 2.21±0.051Ionizedcalcium,mM
Intact 1.29±0.01 1.29±0.01 1.32±0.01 1.32±0.02 1.33±0.02*
PTX
1.08±0.02*
1.05±0.02*
1.05±0.02*
1.09±0.02**
1.13±0.02**
PTX+low
hPTH41-34)
1.25±0.03§ 1.17±0.02§ 1.31±0.02§ 1.32±0.01*§ 1.32±0.01*§ PTX+high hPTH-(1-34)1.34±0.02*11
1.34±0.01*1l
1.35±0.015
1.36±0.01*§1.37±0.02*f
pH
Intact 7.40±0.01 7.40±0.01 7.33±0.02* 7.29±0.02* 7.25±0.02*
PTX 7.40±0.01 7.39±0.01 7.32±0.01*
7.25±0.01**
7.20±0.01** PTX+lowhPTH41-34)
7.39±0.01 7.37±0.01 7.35±0.01* 7.30±0.02*§ 7.23±0.03* PTX+highhPTH41-34)
7.40±0.01 7.40±0.017.36±0.01*1
7.30±0.01*1
7.26±0.01*§
Bicarbonate,mMIntact 23.5±0.8 23.0±0.7 19.3±0.7* 16.5±0.7* 14.8±0.6*
PTX 23.6±0.4 22.8±0.6 18.7±0.1* 15.7±0.5* 13.4±0.6*
PTX+low
hPTH41-34)
22.1±0.9 21.7±1.2 18.9±0.6* 16.1±0.3* 13.7±1.3* PTX+highhPTH41-34)
21.3±0.5 21.2±0.5 18.9±0.2* 15.5±0.4* 14.4±0.5* Pco2, mmHgIntact 38±1 38±2 37±2 35±2 35±1
PTX 39±1 37±1 37±1 36±1 36±1
PTX+low
hPTH41-34)
37±1 35±1 35±1 33±1 33±1PTX+high
hPTH4(1-34)
35±1 34±1 34±1 33±1 33±1.C
HC1,
hC
,HCI,
1 2 3 1 2 3
t ~~~C
0.20- E4
- ~~~~0
0.10- C
200-L
-t+
, , t+Figure 4.Urinaryfractional(F.E.) and absolute (UV) excretion of
inorganicphosphorus (Pi) during controlperiod(C) and 3-hHCO
in-fusion in intactrats(n =6) (-),PTXrats (n = 6) (+), and PTX rats
infusedwith low (5-6 pg/min per g bodywt,n=3)(n)and high(o)
(7-9pg/minper g bodywt,n=5) doses of hPTH-(1-34).Note that onlyfourPTX ratsremainedduring the third hour of HC1 infusion.
Pointsaremeans+SE.
§,
P < 0.05 or less compared with control pe-riod;*,
P <0.05 or less compared with intact rats.t, P< 0.05 or less comparedwithPTXratsinfusedwith low hPTH-(1-34).urinary phosphate, titratable acid, ammonium, and net acid
excretion
rateswereintermediate
tothose obtained with low-dose andhigh-dose
hPTH-( 1-34) infusion in PTX rats, whichclearly confirms
thephysiological
dose-dependence with re-specttoPTHof
the absolutevalues of the various componentsof
urinary
netacid excretion.
However, for a given level of absoluteexcretion,
theevolution
of the latter parameters ofurinary acidification
in responsetoHClloading
in the variousexperimental
groupsmustbeconsidered.
Despite the decrease in the filtered phosphate load during HCl loading, urinary phosphatefractional
and absolute excretion was maintained ordecreased only moderately
inintact andhPTH-( 1-34) infused
PTX ratsduring
HCO
loading(Fig.
4), whereas it greatly de-creased intime-control, nonacidotic
rats(Table I);
duetothesimultaneous
decrease in theurine
pHduring acidosis,
theurinary titratable acid excretion
rate increasedprogressively
andsignificantly
atthethird
hourof acidosis
inintact
rats(P<0.02 vs. control
period)
andwasmaintained
inhPTH-(1-34)-infused
PTX rats(Fig. 5); in PTX rats, the urinaryexcre-tion
ratesof
phosphate andtitratable
acid remained very lowduring acidosis.
Theurinary excretion
rates of ammonium and netacid
similarly increased
inintact,
hPTH-(1-34)-in-fused PTX,
aswellasin PTX rats, althoughdifferent
absolute levels due todifferent circulating
PTHbiological
activities wereevident (Fig.
5). As already mentioned, the presence of an intact endogenouscorticosteroid
secretion that may be stimu-latedduring acidosis
in the rat(14, 17) could have cloudedpossible differences
in the renal response to acidosis due to PTH,particularly
asvarious
degreesof acidosis
wereattained in these four groups of rats as described above.Studies inADXrats(groups
VIII-X).
Asalready
pointed
outin
Methods, this
experimental
series that included ADXrats was
designed
toassessthe roleof
PTHduring
acutemeta-bolic acidosis
in theabsenceof
varying
corticosteroidcirculat-ing
activities.The
arterial
bloodcomposition
in theseratsis
summarized
in Table IV. It mustbepointed
outthatonly
twoof
the six ADX-TPTXratsthatcomposed
groupX havebeenstudied
during
anentire
3-hperiod of acidosis
because fourratsdiedduring
the third hourof
HCl infusion of apparent suddencirculatory failure, probably due to severe acidosis and/or hy-perkalemia. A seventh ADX-TPTX rat that was not included in the group even died during the second hour of HC1 infusion of profound metabolic acidosis. As will be shown below, this was due at least in part to the absence of a significant increase in the urinary net acid excretion rate during
HCl
loading in ADX-TPTX rats. Also, one PTX and one TPTX rat of group II died during the third hour of HCl infusion, as already men-tioned, which suggests that extrarenal factors may also have contributed to the poor endurance to acid loading of PTX animals. A high rate of mortality had previously been observed by others during acute acid loading in nephrectomized TPTX animals (23, 24).During both control and acidosis periods, the GFR was significantly lower in ADX and ADX-TPTX than in intact rats (Table V), presumably because of low circulating levels of glucocorticosteroids in the former animals. However, high uri-nary sodium chloride excretion rates were observed in all rats, which was probably due to the fluid volume expansion and attendant suppression of endogenous aldosterone secretion in adrenal-intact rats secondary to our experimental protol, as mentioned in Methods, which minimized possible differences in body fluid volumes between ADX and adrenal-intact ani-mals. In keeping with the above, there was no significant dif-ference between the various groups of this study in the hemat-ocrit and plasma protein concentration (Tables II and IV). At any rate, ADX and ADX-TPTX rats can be readily compared and did not differ during the control period with respect to GFR and urinary excretion rates of water, sodium, chloride, and potassium.
As shown in Table V, the urinary bicarbonate excretion rate significantly decreased in all groups during
HCl
infusion; the urinary pH also tended to decrease in all groups, but onlysignificantly
at the third hour ofHCl
loading in intact rats. Also, note that the urinary pH tended to be higher in ADX-TPTX than in ADX rats throughout the study despite a more severemetabolic
acidosis in the former animals, probably due to thedefect in collecting duct proton secretion in PTX ani-mals described above. The other components of the renal re-sponse toHCl
loading markedlydiffered
between intact and ADX rats on the one hand, and ADX-TPTX rats on the other hand, whereas acutemetabolic
acidosis was associated with a decrease in GFRof similar
magnitude (20-25%) in all animals (Table V). As shown in Fig. 6, the urinary fractional excretion rate of phosphate increased during HC1 loading in intact and ADX rats, particularly in ADX rats in which it was low during thecontrolperiod.
As aresult, the absoluteexcretion
rates of phosphate (Fig. 6) andtitratable
acid (Fig. 7) weremaintained
in intact and increased in ADX ratsdespite the fall in GFR andphosphate-filtered
loadduring
HC1loading.
Notethat,
conversely, in time-control animals the absolute and fractionalurinary excretion of phosphate progressively decreased with
time in intactrats ordidnotvarysignificantly
inADX ratsin the absenceof
HCl infusion (Table I). Also,
asshown inFig. 7,
significant
increases in theurinary excretion
ratesof
ammo-nium and net acid rapidly occurred in intact and ADX rats.
Particularly, it is worth
pointing
out that theurinary
ammo-niumexcretion
ratesignificantly
increased in ADX ratsvery rapidly during thefirst
hourof
HC1infusion
(P<0.01;Fig.
7). Netacidexcretion increased
43% inintact and 56% inADXratsafter 3h
of acid
loading (P<0.001
for each). On the otherTable III. GFRand Urinary Excretion Rates in Adrenal-intact HCl-loaded Rats (Groups V-
VII)
HOloading(min)
Controlperiod 0-60 60-120 120-180
GFR, ml/min Intact PTX
PTX+low
hPTH41-34)
PTX+highhPTH{(1-34)Urine flow rate, ud/min Intact
PTX
PTX+low
hPTH41-34)
PTX+highhPTH{1-34) Urineosmolality,mosmol/kgH20
Intact PTX
PTX+low
hPTH41-34)
PTX +highhPTH-(1-34) Filteredbicarbonate,nmol/min
Intact PTX
PTX +low
hPTH4{1-34)
PTX+high
hPTH4(1-34)
Urine pH
Intact
PTX
PTX+lowhPTH{1-34)
PTX +highhPTH41-34) (UV)HCO3, nmol/min
Intact PTX
PTX+low
hPTH41-34)
PTX+high
hPTH41-34)
(UV)Na, nmol/min
Intact PTX
PTX +lowhPTH41-34)
PTX+high
hPTH41-34)
(UV)CI, nmol/minIntact
PTX
PTX+lowhPTH-(1-34)
PTX+high
hPTH41-34)
(UV)K, nmol/min
Intact
PTX
PTX+lowhPTH{1-34) PTX+high
hPHTH41-34)
(UV)Ca, nmol/min
Intact PTX
PTX+low
hPTH-(1-34)
PTX+highhPTH{1-34)
(UV)Mg, nmol/min
Intact
PTX
PTX +low
hPTH{(1-34)
PTX+highhPTH41-34)
300.
*: 225
-E
0
150-E
75.
0
4
C
HCI,
h
1 2 3
1600 ~
'g1400 I
1200-E
IZ 800
-1800 Figure 5. Urinary excretion rate of
C: A titratable acid(TA.),ammonium E 1500 NH'),andnetacid(N.A.) during
0 t+/% A control period (C) and 3-hHCO
E
1200- infusion in intact rats (n=6)(-),
PTX
rats (n=6) (+),and PTX90o
o. ratsinfusedwith low(5-6
pg/min
Z 600 + per g body wt, n = 3)
(o)
and high(7-9 pg/min per g bodywt, n=5) (o)dose of hPTH-(1-34).Note that there remained only four
PTX
ratsduring the third hour ofHCOinfusion. Points are means±SE. §, P
<0.05 or less compared with control period; $,P<0.05 or less com-pared with intactrats.t,P<0.05orlesscompared withPTXrats in-fused with lowhPTH-( 1-34).
hand, in ADX-TPTX rats urinary excretion of phosphate,
ti-tratable acid,
andammonium did
not rise during HCIinfu-sion. Thus
netacid
excretion did
notincrease significantly
in two ADX-TPTX ratsafter 3
h orin
six
ADX-TPTXratsafter
1 and 2 hof HCI loading, i.e.,
attimes
whenit
wassignificantly
enhanced in intact
orADX rats. Thus the renal response to acutemetabolic acidosis
wasgreatly blunted
in ADX-TPTX rats as comparedwith intact,
PTX, and ADXanimals.
Discussion
The
findings in the
presentstudy demonstrate in
ratsfor
thefirst time
that an acuteHCl-induced metabolic acidosis
results in arapid
andprogressive increase in
thecirculating
iPTHactivity,
and that
PTHcontributes
to therenal
responseagainst
acutemetabolic acidosis by
enhancing
urinary
phos-phate, titratable
acid, ammonium,
and
thusnetacid excretion.
Theacidosis-induced increase in
thecirculating
iPTHactivity
occurred in both intact and
ADX rats, andwasobserved
de-C Hde-CI,
h C HCI hii2, 31 2 3
<
430
E:400~
0.20-~~ ~ ~
E
0.10
v
200-Li 0. --,-l- D o ,
Figure6.Urinary fractional (FE.) and absolute (UV) excretion of
inorganicphosphorus(Pi) duringcontrolperiod (C)and 3-h HC1 in-fusion in intact (n=6) (-), ADX(n=6) (o),and ADX-TPTX(n
=6)rats(+). Note that there remainedonlytwoADX-TPTXrats
duringthethirdhourof HCO infusion. Pointsaremeans±SE.§, P <0.02orlesscompared with controlperiod.
spite
anincrease
in the plasma ionized calcium concentration and no change in the plasmamagnesium
concentration. Thus apossible stimulation
of endogenous PTH secretion was due tofactors
other than plasmacalcium,
magnesium, and adrenal hormones. Also, the rapid time-course of PTH stimulation ruled out a change in1,25-dihydroxyvitamin
D as a possiblemediator of
theacidosis effect. Strong linear relationships wereobserved between circulating
iPTH levels and plasmabicar-bonate
orhydrogenion
concentration.
Normally the kidneys respond to acute and chronic acid
loading by reducing
theurinarygpH
andbicarbonate
excretion rate, at least temporarily, and by enhancing the urinaryexcre-tion
ratesof phosphate
andtitratable acid
andparticularly
ofammonium
so that netacid excretion
isaugmented
until theentire acid
loadis
excreted out ofthe body. Thefactors
that areresponsible for
therenal adaptation to metabolic acidosis are atpresent incompletely settled. In recentreviews
(25-27) it isgenerally accepted
thatacidosis
itself
exertsmajor
effects
onproximal
anddistal
partsof
the nephron to increase protonsecretion
andbicarbonate
absorption, ammonia production
andexcretion,
and phosphate andtitratable
acid excretion. However, the controlof this important kidney function
byhormonal factors
must beconsidered.
Arolefor
corticosteroid hormonesin
the renalregulation ofacid-base
balance has been proposed inprevious studies,
inwhich
acute and chronic acidloading
were shown toincrease
the plasma aldosteronecon-centration
in humans, rats, and dogs(15-18)
andthe plasma
glucocorticosteroid concentration
indogs and
rats( 14,16) but
not in humans(15,
18). Although aldosteroneis
known tostimulate
protonsecretion
incollecting
ducts(reviewed in
ref-erence28),
to what extent theacidosis-induced increment in
thecirculating aldosterone level contributes
tothe
renal re-sponseagainst
acidosis remains
tobeestablished.
The presenceof
circulating
glucocorticosteroids
has been shown to be neces-saryfor
anormal
adaptive increase
inrenal ammonia
and phosphateexcretion
in response to acute andchronic
meta-bolic acidosis in
the rat(17, 29-32). Results in
the presentstudy
also supportthe
hypothesis
of
a rolefor adrenal
hor-monesin
the renal response to acutemetabolic acidosis
inas-much asabsolute
valuesof urinary excretion
ratesof
phos-phate,ammonium, and
thus netacid
werelower in ADX thanin intact
ratsduring
both control
andacidosis
periods.
Never-theless,
netacid excretion did increase 56% after 3-h HCI
loading
in ADXanimals,
ascompared with
anincrease of
43% inintact
ratsin
the sameexperimental
series
(Fig.
7). This
observation is
in agreementwith results obtained
inprevious
studies
(17,
29)
inwhich
urinary
netacid excretion increased
inchronically
ADX rats,although
atrates thatwerelower than those in intactrats,during
thefirst few hours after ammonium
chloride
loading.
A role for PTH inthis
adaptive
renalre-sponseto acute
metabolic acidosis in intact
and ADXanimals
is
demonstrated
in the present work.In
this study
acuteHCl-induced
metabolic
acidosis in in-tact and ADX rats resulted insignificant increases
in iPTHactivities
that occurreddespite
significant increases
in theplasma ionized calcium concentration.
Serum iPTH wasmea-sured
using
anantiserum directed
against
theNH2-terminal
bioactive
region of
PTH. Wefound
thatthebasal
serumiPTHconcentration
was20-25
pg/ml in
ratsunderourexperimental
conditions,
which is ingood agreement
with values of10-15
pg/ml obtained by
othersin the
ratwith
the sameTable IV.Arterial BloodComposition in ADXHCI-loaded Rats (Groups VIII-X)
Controlperiod(h) HCIloading (h)
0 1 1 2 3
Hematacwnt vnln Intact ADX ADX-TPTX Protein, g/dl Intact ADX ADX-TPTX Sodium,mM Intact ADX ADX-TPTX Potassium,mM Intact ADX ADX-TPTX Chloride,meqiliter Intact ADX ADX-TPTX Pi, mM Intact ADX ADX-TPTX Magnesium,mM Intact ADX ADX-TPTX
Total calcium,mM
Intact
ADX ADX-TPTX
Ionizedcalcium,mM
Intact ADX ADX-TPTX pH Intact ADX ADX-TPTX Bicarbonate,mM Intact ADX ADX-TPTX PCo2,mmHg Intact ADX ADX-TPTX 43.0±0.7 42.9±1.4 43.1±0.8 4.0±0.2 3.6±0.1 3.6±0.2 143±2 145±2 141±3 3.7±0.3 4.0±0.2 3.8±0.1 115±1 114±1 112±1 2.6±0.2 2.9±0.3 3.2±0.1* 0.67±0.02 0.68±0.03 0.66±0.04 2.06±0.05 2.13±0.06 1.87±0.07 1.30±0.01 1.30±0.02 1.27±0.03 7.37±0.01 7.41±0.01 7.38±0.02 21.6±0.3 20.6±0.3 20.8±0.5 39±1 33±1 36±1 43.3±0.7 42.0± 1.2 43.7±0.6 3.9±0.2 3.3±0.2 3.2±0.2 145±2 145±2 141±4 3.7±0.2 3.9±0.1 3.9±0.1 114±1 114±2 113±1 2.5±0.1 2.9±0.2
3.4±0.1*
0.66±0.03 0.67±0.03 0.64±0.03 2.08±0.05 1.98±0.04 1.92±0.06 1.28±0.01 1.28±0.01 1.25±0.03 7.37±0.01 7.40±0.02 7.38±0.02 22.2±0.5 20.4±0.4 20.5±0.6 39±1 34±2 35±1 45.1±0.9 42.5±0.8 44.2±0.6 3.8±0.2 3.3±0.2 3.1±0.2 144±2 143±2 143±3 3.6±0.2 4.1±0.3 4.1±0.2 117±2 115±1 115±2 2.4±0.2 2.9±0.2 3.5±0.1t 0.63±0.02 0.70±0.04 0.65±0.02 2.04±0.06 1.98±0.03 1.95±0.05 1.30±0.0.1 1.30±0.01 1.36±0.05* 7.31±0.01* 7.30±0.03* 7.28±0.03* 18.5±0.8* 16.6±0.8* 16.0±0.9*t 38±1 35±2 36±2 45.7±0.8 42.4±0.8 44.1±0.4 3.8±0.2 3.2±0.2 3.0±0.2 142±2 139±1* 137±3 3.8±0.2 4.4±0.3* 4.8±0.3*t 118±3* 117±1* 118±2* 2.3±0.1 2.8±0.23.7±0.3*§
0.63±0.02 0.67±0.05 0.65±0.01 2.02±0.05 1.97±0.04 1.97±0.06 1.32±0.02 1.34±0.02* 1.39±0.07* 7.25±0.03* 7.24±0.03* 7.18±0.05*t 16.4±0.9* 13.9±1.0* 13.1 1.2*t 37±1 35±2 36±2 45.5±0.8 42.6±0.8 43.8±1.0 3.6±0.2 3.2±0.1 3.0±0.2 140±2* 137±3* 134±4* 4.0±0.2 4.4±0.6*5.0±0.5**§
117±1* 119±2* 117±3* 2.1±0.2 2.9±0.6t3.7±0.6t§
0.63±0.03 0.68±0.05 0.64±0.05 2.02±0.04 1.99±0.02 1.96±0.10 1.33±0.02* 1.33±0.03* 1.35±0.08* 7.19±0.02* 7.18±0.02* 7.13±0.06*$ 14.0±1.2* 12.6±1.2*11.0±
1.9*4
37±2 34±1 33±2
Values aremeans±SE in sixintact rats, six ADX rats, and six ADX-TPTX rats, except at the third hour ofHOloading, at which there
re-mainedonlytwoADX-TPTXrats.Pi, inorganicphosphorus. *P<0.05orlessvs.controlperiodinthesamegroup. *P<0.05orlessvs.
intactrats atthesameperiod. § P<0.05orlessvs. ADX ratsatthesameperiod.
noassay
(19).
Also, valuesranging from
1.0 to 15.5 pg/mlfor
circulating
PTHconcentration
werefound
in normal humansusing
asensitive
cytochemical bioassay (33).
Thus the normalpres-TableV. GFRandUrinary Excretion Rates in ADXHCl-loadedRats (Groups VIII-X)
HOloading(min)
Control period 0-60 60-120 120-180
GFR,ml/min Intact
ADX
ADX-TPTX Urineflowrate,
li/min
Intact
ADX
ADX-TPTX
Urine osmolality,mosmol/kgH20
Intact
ADX ADX-TPTX
UrinepH
Intact
ADX ADX-TPTX
(UV)HCO3, nmol/min Intact
ADX
ADX-TPTX (UV)Na,nmol/min
Intact ADX
ADX-TPTX
(UV)C1, nmol/min
Intact
ADX
ADX-TPTX (UV)K,nmol/min
Intact ADX ADX-TPTX
(UV)Ca, nmol/min
Intact
ADX
ADX-TPTX (UV)Mg,nmol/min
Intact ADX ADX-TPTX
1.04±0.04
0.67±0.03*
0.71±0.06*
56±8
35±4*
42±8 370±46 359± 13 376±46 5.98±0.11 5.64±0.17 5.82±0.30 48±18
17±9 38±23 6,003±1,191 4,365±631 4,892±631 7,243± 1,035 5,341±573
5,863±702
1,174±67 480±56$
484±53*
29±5
6±2*
34±12§158±22
88±8$
120±8
0.93±0.03*
0.61±0.04*t
0.60±0.06*$ 48±11 37±4 30±6 382±65 389±14 404±38 6.03±0.13
5.51±0.15*
5.77±0.20 45±17
8±3* 17±9 4,534±881 4,449±543 3,304±422*
5,753±810 5,636±630
4,333±426* 922±35
538±71$ 496±96$
31±5 10±2 31±16 151±13
86±8*
91±10$0.81±0.03*
0.52±0.05**
0.52±0.07**
0.82±0.04*
0.53±0.01**
0.53±0.01**
37±9 36±2
27±5
41±10
50±5 19±2§
505±133
388±12 409±63 5.88±0.16
5.39±0.18*
5.67±0.20
406±55
327±22 532±675.72±0.16* 5.41±0.13
5.60±0.20 27±12*
7±4* 11±6*
3,773±889*
4,429±231 2,778±390*
5,263±930 5,881±269 3,784±274*
959±99
747±102
593±131$
35±6
15±5
43±19§
124±24
91±10 91±15
21±14*
8±6*
3±1*
4,437±909* 4,905±217
2,227±420*
5,983±1,101 6,287±232 3,945±101*
1,275±193 1,017±167*
528±37*§
37±8
21±12*
77±9*t§
136±31 95±15 100±6
Valuesaremeans±SE. See TableIVfordefinitions ofgroupsand
comparisons.
entwork.
Moreover, high
andlow
serum iPTHconcentrations
in
acidotic
andcalcium-infused
rats,respectively,
wereasso-ciated
with
high
and low NcAMP values.Thus
acutemeta-bolic acidosis increased the
levelof circulating biologically
ac-tive
PTHin
ratsin
this study.
From the dataobtained
inexperiments
designed
toanalyze
the renal response to acuteacid
loading, it is
apparentthat
PTHcontributed
toaugmen-tation
of urinary
netacid excretion. First,
PTX ascompared
with intact
ratshad
amarked
defect in urinary acidification
and netacid excretion
during both control
andacidosis
pe-riods.
Second, the reducedvarious components of
urinary netacid excretion
in PTX rats were restoredin
adose-dependent
manner
by infusion of
hPTH-(
1-34)
inthese animals
(Figs.
4and
5). Although different
absolute valuesof
urinary
netacid
excretion
wereobviously dependent
ondifferent levels of
cir-culating
PTHactivity,
amajor
difference
in theevolution of
the various
componentsof
urinary
netacid
excretion
inre-sponse to